Detection of Aluminium at BioChem – reliable and highly accurate trace analysis
The European Pharmacopoeia requires a limit of 10 microgram/litre for aluminium in WFI (water for injection). Increased values of aluminium are in particular disadvantageous for newborns and for patients needing hemodialsysis. Subsequently, monitoring of aluminium is an essential part of pharmaceutical quality control in certain cases. The problem is the trace analysis of aluminium on the one hand whilst aluminium is also one of the most ubiquitous elements on the other hand. The method of choice at BioChem is AAS (atom absorption spectroscopy) in a graphite tube. By optimizing that method via
Please, find more in our German version of this article |